Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Income towards Parent Company: 2020-2025

Historic Income towards Parent Company for Silence Therapeutics (SLN) over the last 6 years, with Sep 2025 value amounting to -$21.0 million.

  • Silence Therapeutics' Income towards Parent Company rose 41.04% to -$21.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.5 million, marking a year-over-year increase of 18.95%. This contributed to the annual value of -$45.3 million for FY2024, which is 16.45% up from last year.
  • According to the latest figures from Q3 2025, Silence Therapeutics' Income towards Parent Company is -$21.0 million, which was up 23.38% from -$27.4 million recorded in Q2 2025.
  • Silence Therapeutics' 5-year Income towards Parent Company high stood at $12.3 million for Q4 2024, and its period low was -$35.5 million during Q3 2024.
  • For the 3-year period, Silence Therapeutics' Income towards Parent Company averaged around -$16.8 million, with its median value being -$18.6 million (2023).
  • Per our database at Business Quant, Silence Therapeutics' Income towards Parent Company soared by 166.23% in 2024 and then tumbled by 1,134.00% in 2025.
  • MRQ analysis of 5 years shows Silence Therapeutics' Income towards Parent Company stood at -$15.1 million in 2021, then fell by 16.64% to -$17.7 million in 2022, then dropped by 5.23% to -$18.6 million in 2023, then surged by 166.23% to $12.3 million in 2024, then tumbled by 270.36% to -$21.0 million in 2025.
  • Its last three reported values are -$21.0 million in Q3 2025, -$27.4 million for Q2 2025, and -$28.5 million during Q1 2025.